Sumatriptan

Overview

Sumatriptan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL128).

API suppliers (14)

Suppliers of Sumatriptan evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• APITORIA PHARMA PRIVATE LTDIndia2 active DMF GMP on record
• SMS Pharmaceuticals limitedIndia2 active DMF GMP on record
• MSN PHARMACHEM PRIVATE LTDIndia2 active DMF
• CHROMO LABORATORIES INDIA PRIVATE LTDIndia1 active DMF
• Natco Pharma Usa1 active DMF
• MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
• Divis LaboratoriesIndia1 active DMF GMP on record
• MOEHS IBERICA SLSpain1 active DMF GMP on record
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record
• Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
• APOTEX PHARMACHEM INC
• Cipla USA, Inc.USA
• QUIMICA SINTETICA SASpain GMP on record
• Hovione FarmaCiencia SAPortugal GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (52 approved US products), the latest listed US patent on Sumatriptan expires 29 Jan 2036. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide

Canonical SMILES

CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C

InChIKey

KQKPFRSPSRPDEB-UHFFFAOYSA-N